Insulet/PODD

$166.25

0.92%
-
1D1W1MYTD1YMAX

About Insulet

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.

Ticker

PODD

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

James Hollingshead

Employees

3,000

Headquarters

Acton, United States

Insulet Metrics

BasicAdvanced
$11.64B
Market cap
59.00
P/E ratio
$2.82
EPS
1.00
Beta
-
Dividend rate
$11.64B
1.00053
$335.91
$125.82
860.71K
3.508
2.616
186.488
193.231
73.026
40.74%
8.53%
34.12%
10.26%
58.999
6.86
15.863
19.993
318.957
30.02%
4,951.08%
23.34%
205.61%

What the Analysts think about Insulet

Analyst Ratings

Majority rating from 22 analysts.
Buy

Price Targets

Average projection from 18 analysts.
42.45% upside
High $270.00
Low $208.00
$166.25
Current price
$236.83
Average price target

Insulet Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
20.26% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$509.8M
17.82%
Net income
$103.3M
99.04%
Profit margin
20.26%
68.97%

Insulet Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 112.99%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.23
$0.38
$0.71
$1.40
-
Expected
$0.11
$0.26
$0.40
$0.66
$0.38
Surprise
115.74%
44.52%
76.54%
112.99%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Insulet stock?

Insulet (PODD) has a market cap of $11.64B as of April 20, 2024.

What is the P/E ratio for Insulet stock?

The price to earnings (P/E) ratio for Insulet (PODD) stock is 59 as of April 20, 2024.

Does Insulet stock pay dividends?

No, Insulet (PODD) stock does not pay dividends to its shareholders as of April 20, 2024.

When is the next Insulet dividend payment date?

Insulet (PODD) stock does not pay dividends to its shareholders.

What is the beta indicator for Insulet?

Insulet (PODD) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Insulet stock price target?

The target price for Insulet (PODD) stock is $236.83, which is 42.45% above the current price of $166.25. This is an average based on projections from 18 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Insulet stock

Buy or sell Insulet stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing